迪马股份(600565.SH):共同成长计划第二期首次买入2636.7598万股
格隆汇 8 月 25日丨迪马股份(600565.SH)披露共同成长计划第二期实施的进展,收到共同成长计划管理人通知:2020年8月25日,资管计划通过二级市场首次买入迪马股份股票共计2636.7598万股,占公司总股本的1.08%。
按照相关法律法规及共同成长计划的要求,在提取上述共同成长计划资金完成之日起的6个月内(即2021年1月23日前),公司共同成长计划第二期将继续通过资管计划按照共同成长计划规定的股票获取方式完成迪马股份(标的股份)的买入,并根据市场情况在符合相关法律法规的情况下进行合理配资。公司将严格履行窗口期相关禁止规定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.